251 related articles for article (PubMed ID: 28721555)
21. The Role of Baseline Sarcopenia Index in Predicting Chemotherapy-Induced Undesirable Effects and Mortality in Older People with Stage III or IV Non-Small Cell Lung Cancer.
Chen X; Hou L; Shen Y; Wu X; Dong B; Hao Q
J Nutr Health Aging; 2021; 25(7):878-882. PubMed ID: 34409965
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.
Tsukioka T; Nishiyama N; Izumi N; Mizuguchi S; Komatsu H; Okada S; Toda M; Hara K; Ito R; Shibata T
Jpn J Clin Oncol; 2017 Apr; 47(4):363-368. PubMed ID: 28158497
[TBL] [Abstract][Full Text] [Related]
23. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
24. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
[TBL] [Abstract][Full Text] [Related]
25. The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer.
Almugbel FA; Timilshina N; Papadopoulos E; Al-Showbaki L; Alibhai SMH
J Geriatr Oncol; 2022 Apr; 13(3):318-324. PubMed ID: 34924306
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Sci Rep; 2021 Jun; 11(1):11882. PubMed ID: 34088965
[TBL] [Abstract][Full Text] [Related]
27. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract][Full Text] [Related]
28. Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer.
Muchnik E; Loh KP; Strawderman M; Magnuson A; Mohile SG; Estrah V; Maggiore RJ
J Am Geriatr Soc; 2019 May; 67(5):905-912. PubMed ID: 30698276
[TBL] [Abstract][Full Text] [Related]
29. The clinical applicability of ultrasound technique for diagnosis of sarcopenia in hemodialysis patients.
Matsuzawa R; Yamamoto S; Suzuki Y; Imamura K; Harada M; Matsunaga A; Tamaki A; Fukui T; Shimokado K
Clin Nutr; 2021 Mar; 40(3):1161-1167. PubMed ID: 32798065
[TBL] [Abstract][Full Text] [Related]
30. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract][Full Text] [Related]
31. The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Lee SM; Upadhyay S; Lewanski C; Falk S; Skailes G; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Rudd R; Ngai Y; Edwards A; Hackshaw A
Eur J Cancer; 2019 Oct; 120():86-96. PubMed ID: 31499384
[TBL] [Abstract][Full Text] [Related]
32. Utility and safety of maintenance chemotherapy in advanced non-small cell lung cancer across various performance status categories: real-world experience.
Prasad KT; Muthu V; Biswas B; Malik PS; Dabkara D; Ganguly S; Ghosh J; Kataria B; Khurana S; Verma S; Singh N
Curr Probl Cancer; 2020 Jun; 44(3):100565. PubMed ID: 32173058
[TBL] [Abstract][Full Text] [Related]
33. Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study.
Kiss NK; Denehy L; Edbrooke L; Prado CM; Ball D; Siva S; Abbott G; Ugalde A; Fraser SF; Everitt S; Hardcastle N; Wirth A; Daly RM
BMJ Open; 2021 Sep; 11(9):e051665. PubMed ID: 34580100
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
35. Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease.
Lage VKS; Silva GP; Lacerda ACR; Paula FA; Lima LP; Santos JNV; Almeida HC; Pinto AGF; Figueiredo PHS; Costa HS; Bernardo-Filho M; Sá-Caputo DC; Taiar R; Leite HR; Teixeira AL; Mendonça VA
Expert Rev Respir Med; 2021 Apr; 15(4):569-576. PubMed ID: 33197358
[No Abstract] [Full Text] [Related]
36. Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment.
Tobberup R; Carus A; Rasmussen HH; Falkmer UG; Jorgensen MG; Schmidt EB; Jensen NA; Mark EB; Delekta AM; Antoniussen CS; Bøgsted M; Holst M
Clin Nutr; 2021 Feb; 40(2):525-533. PubMed ID: 32600857
[TBL] [Abstract][Full Text] [Related]
37. Measurement of body composition: Agreement between methods of measurement by bioimpedance and computed tomography in patients with non-small cell lung cancer.
Hansen C; Tobberup R; Rasmussen HH; Delekta AM; Holst M
Clin Nutr ESPEN; 2021 Aug; 44():429-436. PubMed ID: 34330501
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
[TBL] [Abstract][Full Text] [Related]
39. Possible Sarcopenia and Impact of Dual-Task Exercise on Gait Speed, Handgrip Strength, Falls, and Perceived Health.
Merchant RA; Chan YH; Hui RJY; Lim JY; Kwek SC; Seetharaman SK; Au LSY; Morley JE
Front Med (Lausanne); 2021; 8():660463. PubMed ID: 33937294
[No Abstract] [Full Text] [Related]
40. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Friedlaender A; Metro G; Signorelli D; Gili A; Economopoulou P; Roila F; Banna G; De Toma A; Camerini A; Christopoulou A; Lo Russo G; Banini M; Galetta D; Jimenez B; Collazo-Lorduy A; Calles A; Baxevanos P; Linardou H; Kosmidis P; Mountzios G; Garassino MC; Addeo A
Acta Oncol; 2020 Sep; 59(9):1058-1063. PubMed ID: 32762415
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
